Implementing the supply of emtricitabine 200mg/tenofovir disoproxil 245mg (TD-FTC) as Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection Patient Group Direction (PGD)

January 27, 2026 Director - Public Health (Other) Approved View on council website